Back to mobile site

Esperion Therapeutics (ESPR) Names Tracy M. Woody to Board

May 30, 2019 4:30 PM EDT Send to a Friend
Esperion (NASDAQ: ESPR) today announced the appointment of Tracy M. Woody as a Class I director, with a term expiring ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login